Novo Nordisk filed a lawsuit against Eli Lilly on Tuesday, July 21, 2026, alleging that its rival’s advertising campaigns for weight-loss and diabetes drugs are misleading consumers by using outdated clinical comparisons. The complaint, filed in U.S.